Vishal Sikri - 31 Dec 2022 Form 5 Insider Report for NEOGENOMICS INC (NEO)

Role: President, Pharma Services
Signature: /s/ Ali Olivo, Attorney-in-Fact
Issuer symbol: NEO
Transactions as of: 31 Dec 2022
Net transactions value: +$1,584
Form type: 5
Filing time: 01 Feb 2023, 16:37:40 UTC
Previous filing: 02 Jun 2022
Next filing: 15 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Small acquisition under Rule 16a-6	$1,584	+225	+0.15%	$7.04	148,680	31 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NEO	Stock Option (Right to Buy)						319,112	31 Dec 2022	Common Stock	319,112	$8.42	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2022. The shares were acquired in transactions exempt from Section 16b-3.
F2	On June 1, 2022, Mr. Sikri was granted 193,799 stock options. These options vest ratably over the first two anniversary dates of the grant date.
F3	On June 1, 2022, Mr. Sikri was granted 125,313 stock options. These options vest ratably over the first four anniversary dates of the grant date.